Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $2.58 billion. The enterprise value is $3.21 billion.
| Market Cap | 2.58B |
| Enterprise Value | 3.21B |
Important Dates
The next estimated earnings date is Thursday, October 8, 2026, before market open.
| Earnings Date | Oct 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 218.06 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 218.06M |
| Shares Outstanding | 218.06M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 110.69% |
| Float | 217.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 38.16 |
| PS Ratio | 2.96 |
| Forward PS | 2.92 |
| PB Ratio | 1.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 80.87 |
| P/OCF Ratio | 31.00 |
| PEG Ratio | 3.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.86, with an EV/FCF ratio of 100.52.
| EV / Earnings | n/a |
| EV / Sales | 3.68 |
| EV / EBITDA | 33.86 |
| EV / EBIT | n/a |
| EV / FCF | 100.52 |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.39.
| Current Ratio | 3.82 |
| Quick Ratio | 2.10 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 8.05 |
| Debt / FCF | 25.47 |
| Interest Coverage | -0.38 |
Financial Efficiency
Return on equity (ROE) is -0.38% and return on invested capital (ROIC) is -0.79%.
| Return on Equity (ROE) | -0.38% |
| Return on Assets (ROA) | -0.40% |
| Return on Invested Capital (ROIC) | -0.79% |
| Return on Capital Employed (ROCE) | -0.68% |
| Weighted Average Cost of Capital (WACC) | 11.94% |
| Revenue Per Employee | $330,197 |
| Profits Per Employee | -$2,997 |
| Employee Count | 2,636 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.76 |
Taxes
| Income Tax | -1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.82% in the last 52 weeks. The beta is 1.76, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | +106.82% |
| 50-Day Moving Average | 10.72 |
| 200-Day Moving Average | 9.36 |
| Relative Strength Index (RSI) | 58.27 |
| Average Volume (20 Days) | 1,554,799 |
Short Selling Information
The latest short interest is 9.93 million, so 4.56% of the outstanding shares have been sold short.
| Short Interest | 9.93M |
| Short Previous Month | 9.43M |
| Short % of Shares Out | 4.56% |
| Short % of Float | 4.58% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
In the last 12 months, Neogen had revenue of $870.40 million and -$7.90 million in losses. Loss per share was -$0.04.
| Revenue | 870.40M |
| Gross Profit | 408.50M |
| Operating Income | -21.60M |
| Pretax Income | -9.00M |
| Net Income | -7.90M |
| EBITDA | 94.70M |
| EBIT | -21.60M |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $185.50 million in cash and $812.60 million in debt, with a net cash position of -$627.10 million or -$2.88 per share.
| Cash & Cash Equivalents | 185.50M |
| Total Debt | 812.60M |
| Net Cash | -627.10M |
| Net Cash Per Share | -$2.88 |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 9.61 |
| Working Capital | 446.40M |
Cash Flow
In the last 12 months, operating cash flow was $83.20 million and capital expenditures -$51.30 million, giving a free cash flow of $31.90 million.
| Operating Cash Flow | 83.20M |
| Capital Expenditures | -51.30M |
| Depreciation & Amortization | 116.30M |
| Net Borrowing | -100.10M |
| Free Cash Flow | 31.90M |
| FCF Per Share | $0.15 |
Margins
Gross margin is 46.93%, with operating and profit margins of -2.48% and -0.91%.
| Gross Margin | 46.93% |
| Operating Margin | -2.48% |
| Pretax Margin | -1.03% |
| Profit Margin | -0.91% |
| EBITDA Margin | 10.88% |
| EBIT Margin | -2.48% |
| FCF Margin | 3.66% |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | -0.31% |
| FCF Yield | 1.24% |
Analyst Forecast
The average price target for Neogen is $13.33, which is 12.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.33 |
| Price Target Difference | 12.68% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 0.97% |
| EPS Growth Forecast (3Y) | 12.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 0.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.93 |
| Piotroski F-Score | 5 |